Posted: February 2023


ATIC recently invited members of the type 1 diabetes community to learn more about us – the first Australasian clinical trial collaborative set up to accelerate development and delivery of immunotherapy treatments for people with type 1 diabetes.

During this online (Zoom) Forum, attendees learned about:

  • The latest ATIC clinical trial – now recruiting (visit for more information)
  • Immunotherapy – what is it and how does it work?
  • ATIC – how and why it was established
  • A participant’s perspective of the clinical trial experience

Host: Dr Michelle So, endocrinologist, researcher, and Lead, ATIC Education & Training Domain.

Panel participants:

  • Professor Tom Kay, ATIC Chair
  • A/Professor John Wentworth, ATIC Clinical Lead Investigator
  • Dr Dorota Pawlak, Chief Scientific Officer, JDRF
  • Ms Fiona McGregor, Deputy Chair, ATIC Community Engagement Panel
  • Ms Kate Wilkinson, Type 1 diabetes clinical trial participant

You can view the video of the webinar here:

We are also documenting the Qs and As from the event, and will make those available soon.

Follow us on our socials: Facebook, Twitter, LinkedIn.